WallStreetZenWallStreetZen

NASDAQ: NCNA
Nucana PLC Stock

$0.85+0.01 (+1.19%)
Updated Jun 1, 2023
NCNA Price
$0.85
Fair Value Price
$1.82
Market Cap
$44.53M
52 Week Low
$0.57
52 Week High
$2.24
P/E
-1.13x
P/B
1.12x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$37.93M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.54
Operating Cash Flow
-$39M
Beta
1.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NCNA Overview

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors and in a Phase 1b/2 clinical trial for patients with advanced colorectal cancer; and NUC-7738, a nucleoside analog that is in Phase 1/2 clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. It has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NCNA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NCNA ($0.85) is undervalued by 53.36% relative to our estimate of its Fair Value price of $1.82 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NCNA ($0.85) is significantly undervalued by 53.36% relative to our estimate of its Fair Value price of $1.82 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NCNA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NCNA due diligence checks available for Premium users.

Be the first to know about important NCNA news, forecast changes, insider trades & much more!

NCNA News

Valuation

NCNA fair value

Fair Value of NCNA stock based on Discounted Cash Flow (DCF)
Price
$0.85
Fair Value
$1.82
Undervalued by
53.36%
NCNA ($0.85) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NCNA ($0.85) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NCNA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NCNA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.13x
Industry
11.46x
Market
52.37x

NCNA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.12x
Industry
5.14x
NCNA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NCNA's financial health

Profit margin

Revenue
$0.0
Net Income
-$9.5M
Profit Margin
0%
NCNA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$58.7M
Liabilities
$20.5M
Debt to equity
0.54
NCNA's short-term assets ($56.73M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NCNA's short-term assets ($56.73M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NCNA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NCNA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$12.5M
Investing
$196.4k
Financing
-$49.4k
NCNA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NCNA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NCNA$44.53M+1.80%-1.13x1.12x
EFTR$44.52M+12.90%-1.22x-9.25x
ELDN$44.34M-6.19%-0.32x0.59x
GRNA$43.99M-0.68%-0.26x2.01x
SNSE$45.23M0.00%-0.97x0.48x

Nucana Stock FAQ

What is Nucana's quote symbol?

(NASDAQ: NCNA) Nucana trades on the NASDAQ under the ticker symbol NCNA. Nucana stock quotes can also be displayed as NASDAQ: NCNA.

If you're new to stock investing, here's how to buy Nucana stock.

What is the 52 week high and low for Nucana (NASDAQ: NCNA)?

(NASDAQ: NCNA) Nucana's 52-week high was $2.24, and its 52-week low was $0.57. It is currently -62.05% from its 52-week high and 49.12% from its 52-week low.

How much is Nucana stock worth today?

(NASDAQ: NCNA) Nucana currently has 52,387,000 outstanding shares. With Nucana stock trading at $0.85 per share, the total value of Nucana stock (market capitalization) is $44.53M.

Nucana stock was originally listed at a price of $16.15 in Sep 28, 2017. If you had invested in Nucana stock at $16.15, your return over the last 5 years would have been -94.74%, for an annualized return of -44.51% (not including any dividends or dividend reinvestments).

How much is Nucana's stock price per share?

(NASDAQ: NCNA) Nucana stock price per share is $0.85 today (as of Jun 1, 2023).

What is Nucana's Market Cap?

(NASDAQ: NCNA) Nucana's market cap is $44.53M, as of Jun 3, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nucana's market cap is calculated by multiplying NCNA's current stock price of $0.85 by NCNA's total outstanding shares of 52,387,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.